AKT/GSK-3 β signaling is altered through downregulation of mTOR during cerebral Ischemia/Reperfusion injury

CONCLUSION: Our findings provide new insight into the cellular responses to ischemia/reperfusion brain injury and will help develop new treatments targeting the AKT signaling pathway for the treatment of ischemic stroke.PMID:35235160 | DOI:10.1007/s11033-022-07247-x

Source: Molecular Biology Reports - March 2, 2022 Category: Molecular Biology Authors: Shengwei Peng Jin-Hua Gu Chun-Ling Dai Khalid Iqbal Fei Liu Cheng-Xin Gong Source Type: research